Published in JAMA on August 19, 1998
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study | NCT00600106
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls | NCT00005108
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One (2014) 6.01
Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Evidence-based common sense? Can Fam Physician (2008) 2.67
Psychosocial factors and public health: a suitable case for treatment? J Epidemiol Community Health (2003) 2.53
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver (2012) 2.35
Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc (2009) 2.33
Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension (2007) 2.31
The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci (2011) 2.26
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. JAMA Intern Med (2014) 2.20
Identifying and avoiding bias in research. Plast Reconstr Surg (2010) 2.19
Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience. Thromb Res (2011) 2.10
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ (2000) 2.06
Why primate models matter. Am J Primatol (2014) 2.05
Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler Thromb Vasc Biol (2008) 2.04
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis (2008) 2.03
Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA (1998) 1.98
Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause (2008) 1.94
The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev (2013) 1.93
Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak (2001) 1.88
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med (2014) 1.87
Hormone replacement therapy. BMJ (2002) 1.83
Explanatory models are needed to integrate RCT and observational data with the patient's unique biology. J R Soc Med (2012) 1.77
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A (2003) 1.77
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med (2006) 1.76
Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med (2011) 1.74
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol (2008) 1.69
Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study. Menopause (2011) 1.67
Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ (2003) 1.63
Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res (2006) 1.63
History of hot flashes and aortic calcification among postmenopausal women. Menopause (2010) 1.63
Six persistent research misconceptions. J Gen Intern Med (2014) 1.61
The haunting of medical journals: how ghostwriting sold "HRT". PLoS Med (2010) 1.60
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol (2009) 1.59
Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics (2011) 1.56
Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm (2008) 1.56
Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg (2012) 1.54
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res (2007) 1.53
Early menopause predicts angina after myocardial infarction. Menopause (2010) 1.52
Hormone replacement therapy: a time for pause. CMAJ (2002) 1.52
Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One (2011) 1.48
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46
Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause (2006) 1.46
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res (2010) 1.45
Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins. Menopause (2015) 1.45
Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest (2001) 1.45
Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause (2015) 1.43
The ethics of aggregation and hormone replacement therapy. Health Care Anal (2001) 1.41
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative. J Womens Health (Larchmt) (2010) 1.40
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. Diabetes Care (2005) 1.39
Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv (2008) 1.39
Use of hormone replacement therapy among cardiac patients at a Canadian academic centre. CMAJ (1999) 1.39
Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol (2009) 1.39
Making decisions about hormone replacement therapy. BMJ (2003) 1.38
Sex, sex steroids, and brain injury. Semin Reprod Med (2009) 1.35
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med (2008) 1.34
Determination of the clinical importance of study results. J Gen Intern Med (2002) 1.34
Debate: The slippery slope of surrogate outcomes. Curr Control Trials Cardiovasc Med (2000) 1.30
Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy. CMAJ (2000) 1.25
Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens (2011) 1.24
Impact of age and sex on sudden cardiovascular death following myocardial infarction. Heart (2002) 1.24
Sex differences in stroke. Cerebrovasc Dis (2008) 1.24
Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx (2004) 1.23
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (2004) 1.22
Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference model. Osteoporos Int (2006) 1.21
Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol (2009) 1.21
Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol (2001) 1.20
Rheumatology: 15. Osteoporosis. CMAJ (2001) 1.20
Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status. BMC Med (2009) 1.18
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol (2011) 1.18
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
Exercise participation, body mass index, and health-related quality of life in women of menopausal age. Br J Gen Pract (2007) 1.17
A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab (2010) 1.16
Women's health in menopause with a focus on hypertension. Neth Heart J (2009) 1.15
Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials. Am J Public Health (2010) 1.15
Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev (2002) 1.14
The impact of clinical trials on the use of hormone replacement therapy. A population-based study. J Gen Intern Med (2005) 1.14
Coronary heart disease in women: a challenge for the 21st century. Clinics (Sao Paulo) (2010) 1.14
Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat Rev Nephrol (2009) 1.12
Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol (2003) 1.12
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer (2013) 1.11
Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy. J Physiol (2004) 1.11
Vascular cell signaling by membrane estrogen receptors. Steroids (2008) 1.11
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health (2005) 1.11
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Left ventricular pseudoaneurysm. J Am Coll Cardiol (1998) 8.81
A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry (1996) 7.80
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Factors associated with the health care utilization of homeless persons. JAMA (2001) 6.61
Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA (1996) 6.53
Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA (1996) 4.89
Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2000) 4.29
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet (1988) 4.12
Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA (1994) 4.01
Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol (1997) 3.66
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA (1996) 3.54
An international comparison of back surgery rates. Spine (Phila Pa 1976) (1994) 3.38
Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol (2001) 3.36
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA (1998) 3.32
The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care (1995) 3.29
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol (1999) 3.19
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
Adequacy and duration of antidepressant treatment in primary care. Med Care (1992) 3.04
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med (1998) 2.97
Positive predictive value of screening mammography by age and family history of breast cancer. JAMA (1993) 2.95
Hysterectomy and urinary incontinence: a systematic review. Lancet (2000) 2.89
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA (1995) 2.69
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A (2001) 2.61
Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. J Acquir Immune Defic Syndr (2001) 2.59
Use of T lymphocyte subset analysis in the case definition for AIDS. J Acquir Immune Defic Syndr (1993) 2.57
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J (1991) 2.47
Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA (1996) 2.44
Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med (1996) 2.36
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol (1988) 2.35
Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry (2001) 2.35
Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol (2004) 2.24
Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology (2009) 2.21
Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol (2001) 2.21
Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol (1999) 2.20
Outcomes of "inadequate" antidepressant treatment. J Gen Intern Med (1995) 2.19
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Intern Med (1991) 2.08
Viable but non-culturable Vibrio cholerae O1 revert to a cultivable state in the human intestine. World J Microbiol Biotechnol (1996) 2.05
Somatization: a spectrum of severity. Am J Psychiatry (1991) 2.03
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet (2003) 2.02
A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry (1992) 2.00
The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS (1993) 2.00
Chronic exposure to outdoor air pollution and lung function in adults. Thorax (2009) 1.98
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol (1991) 1.94
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis (1987) 1.90
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry (2001) 1.83
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health (1998) 1.78
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol (1994) 1.74
Are there detectable differences in quality of care or outcome of depression across primary care providers? Med Care (2000) 1.72
Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology (2011) 1.69
Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc (1998) 1.66
Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66
The randomized clinical trial: bias in analysis. Circulation (1981) 1.64
Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation (2001) 1.61
The education of depressed primary care patients: what do patients think of interactive booklets and a video? J Fam Pract (1997) 1.59
Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol (1996) 1.59
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med (1996) 1.55
Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J Am Geriatr Soc (2000) 1.54
Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart (2009) 1.54
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53
Prevalence and correlates of diabetes in South asian indians in the United States: findings from the metabolic syndrome and atherosclerosis in South asians living in america study and the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord (2010) 1.50
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost (2006) 1.46
Population-based care of depression: effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry (1997) 1.44
The lumpy breast. West J Med (1988) 1.43
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychol Med (2003) 1.40
Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol (1996) 1.39
Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer (1995) 1.39
Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend (1998) 1.39
Carpal tunnel syndrome. West J Med (1988) 1.38
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care (2002) 1.37
Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial. West J Med (2001) 1.35
The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis (1994) 1.34
Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS (2000) 1.32
Comparison by studies in squirrel monkeys, chimpanzees, and adult humans of avian-human influenza A virus reassortants derived from different avian influenza virus donors. J Clin Microbiol (1986) 1.32
Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients. Anesth Analg (2005) 1.29